Bicifadine → 3-Cyclopropanecarbonyl-1-(p-tolyl)-3-azabicyclo[3.1.0]hexane
Reaktionsgleichung
[C:1]1([CH3:13])[CH:6]=[CH:5][C:4]([C:7]23[CH2:12][CH:11]2[CH2:10][NH:9][CH2:8]3)=[CH:3][CH:2]=1.[CH:14]1([C:17](Cl)=[O:18])[CH2:16][CH2:15]1>>[CH:14]1([C:17]([N:9]2[CH2:10][CH:11]3[C:7]([C:4]4[CH:3]=[CH:2][C:1]([CH3:13])=[CH:6][CH:5]=4)([CH2:12]3)[CH2:8]2)=[O:18])[CH2:16][CH2:15]1Komponenten
3
Versuchsvorschrift
In a like manner 1-(p-tolyl)-3-azabicyclo[3.1.0]hexane (Example 36) is reacted with cyclopropanecarbonyl chloride to give 3-cyclopropanecarbonyl-1-(p-tolyl)-3-azabicyclo[3.1.0]hexane which is reduced as above to give 3-cyclopropylmethyl-1-(p-tolyl)-3-azabicyclo[3.1.0]hexane hydrochloride as colorless crystals, m.p. 180°-182° C.
Quellen und Nachweise
- ORD-Eintrag
- ord-cc67e5905b8e4d4fb46c9cf6cc337c8c
- Quelldatensatz
- uspto-grants-1980_04
- Patentnummer
- US04196120